Balyasny Asset Management
PRME icon

Balyasny Asset Management’s Prime Medicine PRME Stock Holding History

Balyasny Asset Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,342
Closed -$47.7K – 2330
2024
Q4 		$47.7K Buy
+16,342
New +$47.7K ﹤0.01% 1845
2024
Q3 		– Sell
-12,101
Closed -$62.2K – 2282
2024
Q2 		$62.2K Buy
+12,101
New +$62.2K ﹤0.01% 1792